HK1103987A1 - Propagation agent and propagation method for natural killer cell - Google Patents

Propagation agent and propagation method for natural killer cell

Info

Publication number
HK1103987A1
HK1103987A1 HK07112502.9A HK07112502A HK1103987A1 HK 1103987 A1 HK1103987 A1 HK 1103987A1 HK 07112502 A HK07112502 A HK 07112502A HK 1103987 A1 HK1103987 A1 HK 1103987A1
Authority
HK
Hong Kong
Prior art keywords
propagation
natural killer
killer cell
agent
propagation method
Prior art date
Application number
HK07112502.9A
Other languages
English (en)
Inventor
Tetsuya Kuhara
Takehito Itoh
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of HK1103987A1 publication Critical patent/HK1103987A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C07K14/19—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
HK07112502.9A 2004-09-15 2007-11-15 Propagation agent and propagation method for natural killer cell HK1103987A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004268041 2004-09-15
PCT/JP2005/016449 WO2006030675A1 (ja) 2004-09-15 2005-09-07 ナチュラルキラー細胞の増殖剤及び増殖方法

Publications (1)

Publication Number Publication Date
HK1103987A1 true HK1103987A1 (en) 2008-01-04

Family

ID=36059930

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07112502.9A HK1103987A1 (en) 2004-09-15 2007-11-15 Propagation agent and propagation method for natural killer cell
HK12103648.6A HK1162954A1 (en) 2004-09-15 2007-11-15 A method for screening for a substance having an action of proliferating natural killer cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK12103648.6A HK1162954A1 (en) 2004-09-15 2007-11-15 A method for screening for a substance having an action of proliferating natural killer cells

Country Status (10)

Country Link
US (3) US20070116675A1 (xx)
EP (2) EP2402034B1 (xx)
JP (2) JP3970916B2 (xx)
KR (2) KR101059724B1 (xx)
CN (2) CN1897973B (xx)
AU (1) AU2005256118B8 (xx)
CA (1) CA2544155C (xx)
HK (2) HK1103987A1 (xx)
NZ (1) NZ546174A (xx)
WO (1) WO2006030675A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101059724B1 (ko) 2004-09-15 2011-08-26 모리나가 뉴교 가부시키가이샤 천연 킬러 세포를 증식시키는 작용을 갖는 물질의 스크리닝방법
CN107779433A (zh) * 2016-08-30 2018-03-09 天津市康婷生物工程有限公司 便捷的刺激nk细胞增殖和分化的饲养层制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5104198A (en) * 1996-11-05 1998-05-29 Wisconsin Alumni Research Foundation Use of conjugated linoleic acid to enhance natural killer lymphocyte function
EP1017407A2 (en) 1997-02-03 2000-07-12 Pharming Intellectual Property BV Useful properties of human lactoferrin and variants thereof
JP3619853B2 (ja) 1999-11-26 2005-02-16 独立行政法人理化学研究所 ナチュラルキラー細胞の増殖方法
WO2002047612A2 (en) * 2000-10-27 2002-06-20 Mannatech, Inc. Dietary supplement compositions
KR101059724B1 (ko) 2004-09-15 2011-08-26 모리나가 뉴교 가부시키가이샤 천연 킬러 세포를 증식시키는 작용을 갖는 물질의 스크리닝방법

Also Published As

Publication number Publication date
CA2544155A1 (en) 2006-03-23
AU2005256118B2 (en) 2007-07-19
KR20060056415A (ko) 2006-05-24
NZ546174A (en) 2009-05-31
EP1790355A1 (en) 2007-05-30
JP4537413B2 (ja) 2010-09-01
EP2402034A1 (en) 2012-01-04
CN1897973B (zh) 2011-11-23
AU2005256118B8 (en) 2008-12-11
CA2544155C (en) 2012-10-16
JPWO2006030675A1 (ja) 2008-05-15
KR100835877B1 (ko) 2008-06-09
WO2006030675A1 (ja) 2006-03-23
KR20070059216A (ko) 2007-06-11
JP2007125038A (ja) 2007-05-24
US7628976B2 (en) 2009-12-08
AU2005256118A1 (en) 2006-04-27
CN1897973A (zh) 2007-01-17
US7629316B2 (en) 2009-12-08
US20070116675A1 (en) 2007-05-24
KR101059724B1 (ko) 2011-08-26
US20080295188A1 (en) 2008-11-27
EP1790355A4 (en) 2009-07-29
HK1162954A1 (en) 2012-09-07
EP2402034B1 (en) 2014-04-16
US20080287365A1 (en) 2008-11-20
EP1790355B1 (en) 2012-12-12
AU2005256118A8 (en) 2008-12-11
CN101658678A (zh) 2010-03-03
JP3970916B2 (ja) 2007-09-05

Similar Documents

Publication Publication Date Title
GB2429717B (en) Cell preservation method
GB2428300B (en) Methods and apparatus for palpation simulation
EP1733772A4 (en) GAME METHOD AND GAME SYSTEM
EP1784931A4 (en) METHOD AND DEVICE FOR TRANSPARENT FORWARDING
EP1955238A4 (en) SIMULATION SYSTEM AND METHOD
EP1744251A4 (en) LOG-IN SYSTEM AND PROCEDURE
IL211089A0 (en) Compositions and methods for cell killing
EP1781386A4 (en) GAME SHOW SYSTEM AND METHOD FOR ITS IMPLEMENTATION
EP1737565A4 (en) COS CLAUS CONFIGURATIONS AND METHODS
IL184062A0 (en) Visco-supplement composition and methods
GB0426005D0 (en) Sram test method and sram test arrangement
ZA200605722B (en) Composition and method
ZA200703018B (en) Method and daevice for batteries
EP1781337A4 (en) METHODS AND COMPOSITIONS FOR CELL ACTIVATION
PT1749090T (pt) Formulação, método e composição para terapia celular
EP1811793A4 (en) CELL SELECTION DEVICE AND CELL SELECTION PROCEDURE
HK1103987A1 (en) Propagation agent and propagation method for natural killer cell
GB0424552D0 (en) Methods and means
HK1122370A1 (en) Method and system to automatically purge serial-use devices
GB0403847D0 (en) Methods and means
GB0405330D0 (en) Enzyme and preparation method
ZA200706038B (en) Visco-supplement composition and methods
EP1938123A4 (en) SHIELD STRUCTURE AND METHOD
EP1965811A4 (en) DEVICE AND METHOD FOR CELL GRAFT
GB0427767D0 (en) Method and system

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180907